Reata Pharmaceuticals Buy Hold or Sell Recommendation

RETADelisted Stock  USD 109.67  3.31  2.93%   
Given the investment horizon of 90 days and your slightly conservative level of risk, our recommendation regarding Reata Pharmaceuticals is 'Not Rated'. Macroaxis provides Reata Pharmaceuticals buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding RETA positions.
  
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
In addition, we conduct extensive research on individual companies such as Reata and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards Reata Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

Execute Reata Pharmaceuticals Buy or Sell Advice

The Reata recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Reata Pharmaceuticals. Macroaxis does not own or have any residual interests in Reata Pharmaceuticals or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Reata Pharmaceuticals' advice using the current market data and latest reported fundamentals.

Time Horizon

Risk Tolerance

Execute Advice
Sell Reata PharmaceuticalsBuy Reata Pharmaceuticals
Not Rated
For the selected time horizon Reata Pharmaceuticals has a Risk Adjusted Performance of 0.0484, Jensen Alpha of 0.2114, Total Risk Alpha of (0.42), Sortino Ratio of 0.021 and Treynor Ratio of (1.50)
Macroaxis provides advice on Reata Pharmaceuticals to complement and cross-verify current analyst consensus on Reata Pharmaceuticals. Our recommendation engine determines the firm's potential to grow exclusively from the perspective of an investor's current risk tolerance and investing horizon. To make sure Reata Pharmaceuticals is not overpriced, please check all Reata Pharmaceuticals fundamentals, including its net income, short ratio, and the relationship between the price to sales and debt to equity . Given that Reata Pharmaceuticals has a price to earning of (28.13) X, we recommend you to check out Reata Pharmaceuticals market performance and probability of bankruptcy to ensure the company can sustain itself in the current economic cycle given your recent risk tolerance and investing horizon.

Reata Pharmaceuticals Trading Alerts and Improvement Suggestions

Reata Pharmaceuticals is not yet fully synchronised with the market data
Reata Pharmaceuticals has a very high chance of going through financial distress in the upcoming years
The company reported the previous year's revenue of 2.22 M. Net Loss for the year was (311.9 M) with loss before overhead, payroll, taxes, and interest of (167.63 M).
Reata Pharmaceuticals currently holds about 481.47 M in cash with (204.27 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 13.19.
Over 88.0% of the company shares are owned by institutional investors

Reata Pharmaceuticals Returns Distribution Density

The distribution of Reata Pharmaceuticals' historical returns is an attempt to chart the uncertainty of Reata Pharmaceuticals' future price movements. The chart of the probability distribution of Reata Pharmaceuticals daily returns describes the distribution of returns around its average expected value. We use Reata Pharmaceuticals price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Reata Pharmaceuticals returns is essential to provide solid investment advice for Reata Pharmaceuticals.
Mean Return
0.21
Value At Risk
-3.51
Potential Upside
5.24
Standard Deviation
3.90
   Return Density   
       Distribution  
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Reata Pharmaceuticals historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Note: Disposition of 49701 shares by Michael Wortley of Reata Pharmaceuticals subject to Rule 16b-3 [view details]

Reata Pharmaceuticals Market Momentum

Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Reata . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.

About Reata Pharmaceuticals Buy or Sell Advice

When is the right time to buy or sell Reata Pharmaceuticals? Buying financial instruments such as Reata Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.

Use Investing Ideas to Build Portfolios

In addition to having Reata Pharmaceuticals in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Music and Video Thematic Idea Now

Music and Video
Music and Video Theme
Companies specializing in music, video and movie production and distribution. The Music and Video theme has 36 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Music and Video Theme or any other thematic opportunities.
View All  Next Launch
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.

Other Consideration for investing in Reata Stock

If you are still planning to invest in Reata Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Reata Pharmaceuticals' history and understand the potential risks before investing.
Share Portfolio
Track or share privately all of your investments from the convenience of any device
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Commodity Directory
Find actively traded commodities issued by global exchanges
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets